Correlation Between Salesforce and BB Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Salesforce and BB Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Salesforce and BB Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Salesforce and BB Biotech AG, you can compare the effects of market volatilities on Salesforce and BB Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Salesforce with a short position of BB Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Salesforce and BB Biotech.

Diversification Opportunities for Salesforce and BB Biotech

0.13
  Correlation Coefficient

Average diversification

The 3 months correlation between Salesforce and BBZA is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding Salesforce and BB Biotech AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BB Biotech AG and Salesforce is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Salesforce are associated (or correlated) with BB Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BB Biotech AG has no effect on the direction of Salesforce i.e., Salesforce and BB Biotech go up and down completely randomly.

Pair Corralation between Salesforce and BB Biotech

Considering the 90-day investment horizon Salesforce is expected to generate 1.37 times more return on investment than BB Biotech. However, Salesforce is 1.37 times more volatile than BB Biotech AG. It trades about 0.23 of its potential returns per unit of risk. BB Biotech AG is currently generating about 0.07 per unit of risk. If you would invest  29,801  in Salesforce on September 3, 2024 and sell it today you would earn a total of  3,198  from holding Salesforce or generate 10.73% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy95.24%
ValuesDaily Returns

Salesforce  vs.  BB Biotech AG

 Performance 
       Timeline  
Salesforce 

Risk-Adjusted Performance

21 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Salesforce are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Salesforce displayed solid returns over the last few months and may actually be approaching a breakup point.
BB Biotech AG 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BB Biotech AG has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, BB Biotech is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Salesforce and BB Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Salesforce and BB Biotech

The main advantage of trading using opposite Salesforce and BB Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Salesforce position performs unexpectedly, BB Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BB Biotech will offset losses from the drop in BB Biotech's long position.
The idea behind Salesforce and BB Biotech AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings